Day: April 2, 2021

NEW YORK, April 02, 2021 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) (the “Company”) announced today that it has completed the pricing and allocation of the previously announced $1.5 billion refinancing of its existing credit facilities and senior notes. The refinancing is expected to close on April 13, 2021, subject to customary closing conditions. Amy O’Keefe, the Company’s CFO, commented, “We are pleased with this strong demonstration of support from the finance community, which recognizes the strength of WW’s business model and financial performance. This refinancing further strengthens our balance sheet and enhances our ability to drive tech-enabled innovation and Digital subscriber growth, fueling value creation for lenders and shareholders.” The leverage neutral refinancing will include the following:the...

EMERYVILLE, Calif., April 02, 2021 (GLOBE NEWSWIRE) — NMI Holdings, Inc. (Nasdaq: NMIH) today reported selected operating statistics for the month of March 2021. At March 31, 2021, the company reported 11,090 loans in default and a default rate of 2.54%.  Default Activity as of:  3/31/2020   6/30/2020   9/30/2020   12/31/2020   1/31/2021   2/28/2021   3/31/2021Number of loans in default (1) 1,449   10,816   13,765   12,209   11,905   11,648   11,090Default rate (2) 0.38%   2.90%   3.60%   3.06%   2.90%   2.77%   2.54%      New Insurance Written During:    QuarterEnded3/31/2020   QuarterEnded6/30/2020   QuarterEnded9/30/2020   QuarterEnded12/31/2020   MonthEnded1/31/2021   MonthEnded2/28/2021   MonthEnded3/31/2021Weighted average                FICO   757   762   764   761   756   755   754Loan-to-value...

NASHVILLE, Tenn., April 02, 2021 (GLOBE NEWSWIRE) — SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the first medtech platform for teeth straightening, today announced the appointment of Ted Ward as a director on its Board. Ward is a respected marketing titan with over three decades of experience, most recently at the helm of the marketing team at insurance giant GEICO, where he led the creation of the company’s award-winning disruptive marketing campaigns and solidified the brand as an industry innovator in the minds of consumers. “Ted brings invaluable marketing expertise in guiding a challenger brand to unseat the incumbent market leader, and we look forward to having Ted help SmileDirectClub’s award-winning marketing team go even further and faster,” said David Katzman, Chief Executive Officer...

SHANGHAI, China, April 02, 2021 (GLOBE NEWSWIRE) — Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced that it will release its financial results for the fourth quarter and full year 2020 before the U.S. markets open on Friday, April 9, 2021. The company will conduct a conference call on Friday, April 9, 2021 at 8:00 AM U.S. Eastern Time (8:00 PM Beijing/Hong Kong Time).                What:   Jiayin Group Fourth Quarter and Full Year 2020 Earnings Conference Call         When:   8:00 am U.S. Eastern time on Friday, April 9th, 2021         Webcast:   http://ir.jiayin-fintech.com/              Please register in advance to join the conference using the link provided below and dial in 10 minutes before the call is scheduled to begin. Conference...

– Submission precedes expected NDA filing for dovitinib in 2021– Premarket Approval will allow U.S. marketing of DRP-Dovitinib as companion diagnostic to dovitinib Press release Hørsholm, Denmark (2 April 2021) Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced the submission of a premarket approval application (PMA) to the U.S. Food and Drug Administration (FDA) for DRP®-Dovitinib, the Company’s validated companion diagnostic for the drug dovitinib. Dovitinib is a small molecule, pan-tyrosine kinase inhibitor licensed from Novartis, and is Allarity’s most advanced clinical asset.  This milestone marks the first time that Allarity has sought regulatory approval for one of its drug-specific DRP®s used to guide patient therapy. Allarity’s unique DRP® biomarker technology makes it possible to predict whether...

2 April 2021 Disclosure of the total number of voting rights and sharesforming the share capital as at 31 March 2021 Information pursuant to article L. 233-8 II of the Code de commerce and articles 223-16 and 223-11 of the AMF General regulation (Règlement général de l’Autorité des marchés financiers)Date Number of shares with a nominal value of €7 Gross number ofvoting rights31 March 2021 371,201,793 371,201,793  About Alstom    Leading societies to a low carbon future, Alstom develops and markets mobility solutions that provide the sustainable foundations for the future of transportation. Alstom’s products portfolio ranges from high-speed trains, metros, monorail, trams and e-buses to integrated systems, customised services, infrastructure, signalling and digital mobility solutions. With Bombardier Transportation joining...

 2 avril 2021 Déclaration du nombre total de droits de vote et d’actionscomposant le capital social au 31 mars 2021 Information prévue par l’article L. 233-8 II du Code de commerce et des articles 223-16 et 223-11 du Règlement général de l’Autorité des marchés financiers : Date Nombre d’actionsde €7 de nominal Nombre totalde droits de vote brut31 mars 2021 371 201 793 371 201 793  A propos d’Alstom    Ouvrant la voie de la transition énergétique, Alstom développe et commercialise des solutions de mobilité qui constituent des fondations durables pour l’avenir du transport. Son portefeuille de produits comprend notamment des trains à grande vitesse, des métros, le monorail, des trams et des bus électriques ainsi que des systèmes intégrés, des services sur mesure, de l’infrastructure, des solutions de signalisation et des...

Tustin, CA, April 02, 2021 (GLOBE NEWSWIRE) — Freeze Tag (OTC: FRZT), a leading creator of location-based mobile social games, announced today that Merrell, the global leader in outdoor performance and lifestyle footwear and apparel, launched a fan engagement event using the Eventzee scavenger hunt app. Utilizing Eventzee technology, the “Atlanta Scavenger Hunt presented by Merrell” encourages both fans and community members alike to celebrate the great outdoors throughout the city. Those in the Atlanta, GA area can download the Eventzee app and enter the join code “stepfurther” to participate in the ongoing event. The virtual event features photo, video, text, quiz, and gps challenges. Through photos and videos, players can share their favorite Merrell gear and landmarks in Atlanta. Text and quiz challenges will test players’ knowledge...

荷兰乌得勒支和美国费城, April 02, 2021 (GLOBE NEWSWIRE) — 专注于运用其双特异性γ-δ T细胞结合物（bsTCEs）专业知识来改变癌症疗法的生物技术公司LAVA Therapeutics N.V.（Nasdaq：LVTX）今天宣布任命Karen Wilson担任董事会成员兼审计委员会主席。Wilson女士将带来生命科学行业30多年的财务和领导经验。 首席执行官兼总裁Stephen Hurly表示：“我很高兴欢迎Karen加入我们董事会。她在我们公司激动人心的时刻加入我们行列，因为我们的首个γ-δ bsTCE候选药物将进入临床阶段。她在领导金融机构助推各种临床和商业阶段的公共生命科学公司方面拥有丰富的经验，这对LAVA推进我们旨在改善患者结果和为股东创造价值的产品线将非常宝贵。” Wilson女士是一位生物制药金融高管和董事会成员，在生命科学公司的整个金融、战略和风险管理领域堪称经验丰富。她目前在Angion Biomedica、Connect Biopharma和Vaxart, Inc.董事会任职。她最近曾任Jazz Pharmaceuticals plc财务高级副总裁至2020年9月，之后担任财务副总裁兼首席会计官。在2011年2月加入Jazz Pharmaceuticals之前，Wilson女士曾在PDL BioPharma, Inc.担任财务副总裁兼首席会计官，此前她还曾担任咨询公司Wilson Crisler LLC的委托人、ViroLogic, Inc.首席财务官、Novare Surgical Systems, Inc.首席财务官兼运营副总裁，以及担任德勤会计师事务所顾问兼审计师。Wilson女士是一位注册会计师，获得加州大学伯克利分校商业学士学位。 Wilson女士表示：“LAVA在IPO成功之后，预计在2021年将有两种候选药物进入临床阶段，我非常兴奋能加入我们董事会。我对LAVA平台有可能改变癌症治疗前景的潜力感到非常兴奋。我期待着与董事会和管理团队的其他成员合作，在LAVA的成功基础上再接再厉，优化其肿瘤学方面独特的γ-δ...

Alstom extends its expertise in braking systemswith the acquisition of Flertex April 2, 2021 – Alstom is continuing to implement its Alstom in Motion strategic plan with the acquisition of Flertex, a group specialised in the design and manufacture of brake linings (pads and shoes) for braking systems, particularly for the rail industry but also for other industrial applications. This acquisition expands and strengthens Alstom’s expertise in braking systems, a key element in the overall technical performance of trains. It comes only a few months after that of IBRE, a company specialised in the development, manufacture, and supply of cast-iron or steel brake discs. This acquisition also represents a promising development opportunity for Flertex and its employees. “We are pleased with this acquisition which, similarly to IBRE,...